Cargando…
miR-23b-3p Inhibits the Oncogenicity of Colon Adenocarcinoma by Directly Targeting NFE2L3
BACKGROUND AND AIMS: MicroR-23b-3p (miR-23b-3p) has been found to be abnormally expressed in a variety of malignant tumors and to play a role in tumor inhibition or promotion. However, the regulatory mechanism of miR-23b-3p in COAD remains unclear. The purpose of this study was to investigate the cl...
Autores principales: | Huang, Guohong, Yang, Yimei, Lv, Mengxin, Huang, Tian, Zhan, Xiaoyan, Yao, Yingjie, Hou, Jianghou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712119/ https://www.ncbi.nlm.nih.gov/pubmed/34966429 http://dx.doi.org/10.1155/2021/8493225 |
Ejemplares similares
-
Novel lncRNA SFTA1P Promotes Tumor Growth by Down-Regulating miR-4766-5p via PI3K/AKT/mTOR Signaling Pathway in Hepatocellular Carcinoma
por: Huang, Guohong, et al.
Publicado: (2020) -
Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
por: Jin, Xing, et al.
Publicado: (2021) -
Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal Cancer
por: Zaman, Mohd Saif, et al.
Publicado: (2012) -
Regulation of VEGFA, KRAS, and NFE2L2 Oncogenes by MicroRNAs in Head and Neck Cancer
por: Cuzziol, Caroline Izak, et al.
Publicado: (2022) -
Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2
por: Yang, Xiaodong, et al.
Publicado: (2022)